Marginal Level Dystrophin Expression Improves Clinical Outcome in a Strain of Dystrophin/Utrophin Double Knockout Mice

Genetic Background Affects Properties of Satellite Cells and mdx Phenotypes

(2010) So-ichiro Fukada et al.   AMERICAN JOURNAL OF PATHOLOGY

Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice

(2010) Mayank Verma et al.   HUMAN MOLECULAR GENETICS

Gender influences cardiac function in the mdx model of duchenne cardiomyopathy

(2010) Brian Bostick et al.   MUSCLE & NERVE

Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping

(2010) Chalermchai Mitrpant et al.   Current Molecular Pharmacology

Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation

(2009) D. Merrick et al.   Disease Models & Mechanisms

Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice

(2009) Dejia Li et al.   HUMAN MOLECULAR GENETICS

Latent TGF-β–binding protein 4 modifies muscular dystrophy in mice

(2009) Ahlke Heydemann et al.   JOURNAL OF CLINICAL INVESTIGATION

Coinheritance of Noonan syndrome and Becker muscular dystrophy

(2009) Argirios Dinopoulos et al.   NEUROMUSCULAR DISORDERS

Preservation of Muscle Force in Mdx3cv Mice Correlates with Low-Level Expression of a Near Full-Length Dystrophin Protein

(2008) Dejia Li et al.   AMERICAN JOURNAL OF PATHOLOGY